🇺🇸 FDA
Patent

US 10550386

Monomers and oligonucleotides comprising cycloaddition adduct(s)

granted A61KA61K31/7088A61K31/711

Quick answer

US patent 10550386 (Monomers and oligonucleotides comprising cycloaddition adduct(s)) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/7088, A61K31/711, A61K31/713, A61K47/545